{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:40:10Z","timestamp":1791398410496,"version":"4.3.3"},"reference-count":170,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"the National Institutes of Health National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA035714"],"award-info":[{"award-number":["DA035714"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"the National Institutes of Health National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA047924"],"award-info":[{"award-number":["DA047924"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"the National Institutes of Health National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA057866"],"award-info":[{"award-number":["DA057866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"the National Institutes of Health National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA057163"],"award-info":[{"award-number":["DA057163"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neurodegenerative diseases affect millions of people worldwide. Neurodegenerative diseases result from progressive damage to nerve cells in the brain or peripheral nervous system connections that are essential for cognition, coordination, strength, sensation, and mobility. Dysfunction of these brain and nerve functions is associated with Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease, Amyotrophic lateral sclerosis, and motor neuron disease. In addition to these, 50% of people living with HIV develop a spectrum of cognitive, motor, and\/or mood problems collectively referred to as HIV-Associated Neurocognitive Disorders (HAND) despite the widespread use of a combination of antiretroviral therapies. Neuroinflammation and neurotransmitter systems have a pathological correlation and play a critical role in developing neurodegenerative diseases. Each of these diseases has a unique pattern of dysregulation of the neurotransmitter system, which has been attributed to different forms of cell-specific neuronal loss. In this review, we will focus on a discussion of the regulation of dopaminergic and cholinergic systems, which are more commonly disturbed in neurodegenerative disorders. Additionally, we will provide evidence for the hypothesis that disturbances in neurotransmission contribute to the neuronal loss observed in neurodegenerative disorders. Further, we will highlight the critical role of dopamine as a mediator of neuronal injury and loss in the context of NeuroHIV. This review will highlight the need to further investigate neurotransmission systems for their role in the etiology of neurodegenerative disorders.<\/jats:p>","DOI":"10.3390\/ijms242015340","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T02:54:43Z","timestamp":1697684083000},"page":"15340","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0289-125X","authenticated-orcid":false,"given":"Sarah E.","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, 715 Sumter Street, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abagail B.","family":"Cirincione","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, 715 Sumter Street, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catya","family":"Jimenez-Torres","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, 715 Sumter Street, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, 715 Sumter Street, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"ref_1","first-page":"313","article-title":"The epidemiology of alzheimer\u2019s disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019","volume":"9","author":"Ou","year":"2021","journal-title":"Front. Public Health"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., and Karaman, R. (2020). Comprehensive review on alzheimer\u2019s disease: Causes and treatment. Molecules, 25.","DOI":"10.3390\/molecules25245789"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: Etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"ref_5","first-page":"9343514","article-title":"Aducanumab therapy to treat alzheimer\u2019s disease: A narrative review","volume":"2022","author":"Beshir","year":"2022","journal-title":"Int. J. Alzheimers Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1523\/JNEUROSCI.22-20-08951.2002","article-title":"Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis","volume":"22","author":"Larsen","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","article-title":"Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons","volume":"62","author":"Mosharov","year":"2009","journal-title":"Neuron"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ceca.2006.08.016","article-title":"Mitochondrial calcium signalling and cell death: Approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis","volume":"40","author":"Das","year":"2006","journal-title":"Cell Calcium"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/pr.114.010397","article-title":"Regulation of the dopamine and vesicular monoamine transporters: Pharmacological targets and implications for disease","volume":"67","author":"German","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.neuro.20.1.125","article-title":"The role of vesicular transport proteins in synaptic transmission and neural degeneration","volume":"20","author":"Liu","year":"1997","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuint.2018.11.004","article-title":"Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters","volume":"122","author":"Mulvihill","year":"2019","journal-title":"Neurochem. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996","article-title":"The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons","volume":"16","author":"Nirenberg","year":"1996","journal-title":"J. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Predescu, D.-V., Cre\u021boiu, S.M., Cre\u021boiu, D., Pavelescu, L.A., Suciu, N., Radu, B.M., and Voinea, S.-C. (2019). G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225568"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.110.069039","article-title":"Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters","volume":"79","author":"Guptaroy","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1046\/j.1471-4159.1999.0732406.x","article-title":"Dopamine neuronal transport kinetics and effects of amphetamine","volume":"73","author":"Jones","year":"1999","journal-title":"J. Neurochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1073\/pnas.0403299101","article-title":"Dopamine transporters depolarize neurons by a channel mechanism","volume":"101","author":"Carvelli","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shan, J., Javitch, J.A., Shi, L., and Weinstein, H. (2011). The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016350"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"109239","DOI":"10.1016\/j.neuropharm.2022.109239","article-title":"SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice","volume":"220","author":"Zhu","year":"2022","journal-title":"Neuropharmacology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1021\/acs.jmedchem.6b01373","article-title":"Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10484","DOI":"10.1021\/bi700429z","article-title":"Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching","volume":"46","author":"Adkins","year":"2007","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/bi801696n","article-title":"Proline-directed phosphorylation of the dopamine transporter N-terminal domain","volume":"48","author":"Gorentla","year":"2009","journal-title":"Biochemistry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25178","DOI":"10.1074\/jbc.M200294200","article-title":"Dopamine transporters are phosphorylated on N-terminal serines in rat striatum","volume":"277","author":"Foster","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"40442","DOI":"10.1074\/jbc.M501969200","article-title":"Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms","volume":"280","author":"Cervinski","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"22168","DOI":"10.1074\/jbc.M301845200","article-title":"The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines","volume":"278","author":"Loder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1021\/acschemneuro.8b00558","article-title":"Palmitoylation by multiple DHHC enzymes enhances dopamine transporter function and stability","volume":"10","author":"Bolland","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/sj.emboj.7601656","article-title":"Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.expneurol.2017.05.010","article-title":"A peptide disrupting the D2R-DAT interaction protects against dopamine neurotoxicity","volume":"295","author":"Su","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuropharm.2005.04.016","article-title":"Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: Receptor binding and behavioral studies","volume":"49","author":"Nguyen","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pharmthera.2018.01.009","article-title":"The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction","volume":"186","author":"Sambo","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/npp.2017.291","article-title":"Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway","volume":"43","author":"Hedges","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40263-018-0580-y","article-title":"VMAT2 inhibitors in neuropsychiatric disorders","volume":"32","author":"Tarakad","year":"2018","journal-title":"CNS Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mam.2012.07.005","article-title":"SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine","volume":"34","author":"Lawal","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1073\/pnas.1402134111","article-title":"Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo","volume":"111","author":"Lohr","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.119.258699","article-title":"GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine","volume":"371","author":"Lee","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(98)00850-4","article-title":"Treatment with a polyunsaturated fatty acid prevents deleterious effects of Ro4-1284","volume":"365","author":"Yehuda","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-12-420118-7.00002-0","article-title":"The vesicular monoamine transporter-2: An important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse","volume":"69","author":"Nickell","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1471-4159.2006.04326.x","article-title":"The vesicular monoamine transporter 2 contains trafficking signals in both its N-glycosylation and C-terminal domains","volume":"100","author":"Yao","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1600-0854.2008.00771.x","article-title":"Trafficking of vesicular neurotransmitter transporters","volume":"9","author":"Fei","year":"2008","journal-title":"Traffic"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuroscience.2013.11.059","article-title":"N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux","volume":"259","author":"Torres","year":"2014","journal-title":"Neuroscience"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bye, L.J., Finol-Urdaneta, R.K., Tae, H.-S., and Adams, D.J. (2023). Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases. Int. J. Biochem. Cell Biol., 157.","DOI":"10.1016\/j.biocel.2023.106387"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0896-6273(03)00358-1","article-title":"Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory","volume":"38","author":"Warburton","year":"2003","journal-title":"Neuron"},{"key":"ref_44","unstructured":"Sam, C., and Bordoni, B. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_45","unstructured":"Waxenbaum, J.A., Reddy, V., and Varacallo, M. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0197-0186(02)00044-X","article-title":"Regulation of acetylcholine synthesis and storage","volume":"41","author":"Prado","year":"2002","journal-title":"Neurochem. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1038\/s41598-018-26176-z","article-title":"Cholinergic activity is essential for maintaining the anterograde transport of Choline Acetyltransferase in Drosophila","volume":"8","author":"Dey","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fphys.2017.00005","article-title":"The multifaceted role of SNARE proteins in membrane fusion","volume":"8","author":"Han","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"610964","DOI":"10.3389\/fnmol.2020.610964","article-title":"The neuromuscular junction in health and disease: Molecular mechanisms governing synaptic formation and homeostasis","volume":"13","author":"Cossins","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_50","unstructured":"Trang, A., and Khandhar, P.B. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_51","unstructured":"Carlson, A.B., and Kraus, G.P. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"104810","DOI":"10.1016\/j.neuint.2020.104810","article-title":"Modulation of sodium-coupled choline transporter CHT function in health and disease","volume":"140","author":"Ojiakor","year":"2020","journal-title":"Neurochem. Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2014.01.029","article-title":"Merging old and new perspectives on nicotinic acetylcholine receptors","volume":"89","author":"Papke","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1039\/D2MD00188H","article-title":"Synthesis of full-length homodimer \u03b1D-VxXXB that targets human \u03b17 nicotinic acetylcholine receptors","volume":"13","author":"Ho","year":"2022","journal-title":"RSC Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"108256","DOI":"10.1016\/j.neuropharm.2020.108256","article-title":"Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction","volume":"177","author":"Wittenberg","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: From structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/09687680802035675","article-title":"Assembly and trafficking of nicotinic acetylcholine receptors (Review)","volume":"25","author":"Millar","year":"2008","journal-title":"Mol. Membr. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bcp.2013.06.023","article-title":"Biogenesis, trafficking and up-regulation of nicotinic ACh receptors","volume":"86","author":"Colombo","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer\u2019s disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2174\/138161206775474224","article-title":"Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer\u2019s disease pyramidal neurons","volume":"12","author":"Nagele","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_62","unstructured":"Kudlak, M., and Tadi, P. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2019.10.007","article-title":"Targeting muscarinic acetylcholine receptors for the treatment of psychiatric and neurological disorders","volume":"40","author":"Moran","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/BJ20121662","article-title":"Regulation of cholinergic activity by the vesicular acetylcholine transporter","volume":"450","author":"Prado","year":"2013","journal-title":"Biochem. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"13400","DOI":"10.1021\/bi9802263","article-title":"Kinetic parameters for the vesicular acetylcholine transporter: Two protons are exchanged for one acetylcholine","volume":"37","author":"Nguyen","year":"1998","journal-title":"Biochemistry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-2011-110002","article-title":"Disturbed neurotransmitter transporter expression in Alzheimer\u2019s disease brain","volume":"26","author":"Chen","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","article-title":"The different autophagy degradation pathways and neurodegeneration","volume":"110","author":"Fleming","year":"2022","journal-title":"Neuron"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2501279","DOI":"10.1155\/2022\/2501279","article-title":"Focus on the mechanisms and functions of pyroptosis, inflammasomes, and inflammatory caspases in infectious diseases","volume":"2022","author":"Song","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"879021","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: A review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Mangalmurti, A., and Lukens, J.R. (2022). How neurons die in Alzheimer\u2019s disease: Implications for neuroinflammation. Curr. Opin. Neurobiol., 75.","DOI":"10.1016\/j.conb.2022.102575"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","article-title":"The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer\u2019s disease","volume":"68","author":"Milner","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","article-title":"Pyroptosis in Alzheimer\u2019s disease: Cell type-specific activation in microglia, astrocytes and neurons","volume":"145","author":"Moonen","year":"2023","journal-title":"Acta Neuropathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.conb.2020.04.001","article-title":"Traffic signaling: New functions of huntingtin and axonal transport in neurological disease","volume":"63","author":"Vitet","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Paldino, E., and Fusco, F.R. (2022). Emerging role of NLRP3 inflammasome\/pyroptosis in huntington\u2019s disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158363"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-022-02419-9","article-title":"A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington\u2019s disease","volume":"19","author":"Chen","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.14336\/AD.2019.1125","article-title":"Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer\u2019s Disease","volume":"11","author":"Wong","year":"2020","journal-title":"Aging Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fnins.2018.00419","article-title":"Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A\/B in the Hippocampus, but Not in the Cortex","volume":"12","author":"Quartey","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Rabbito, A., Dulewicz, M., Kulczy\u0144ska-Przybik, A., and Mroczko, B. (2020). Biochemical markers in alzheimer\u2019s disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061989"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Bukke, V.N., Archana, M., Villani, R., Romano, A.D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., and Cassano, T. (2020). The dual role of glutamatergic neurotransmission in alzheimer\u2019s disease: From pathophysiology to pharmacotherapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207452"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of gabaergic neurotransmission in alzheimer\u2019s disease","volume":"8","author":"Li","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: Functions, Signaling, and Association with Neurological Diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","article-title":"Dopamine in Parkinson\u2019s disease","volume":"522","author":"Latif","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13024-019-0332-6","article-title":"Impaired dopamine metabolism in Parkinson\u2019s disease pathogenesis","volume":"14","author":"Masato","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnana.2020.00026","article-title":"Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson\u2019s Disease and Adverse Effects of L-DOPA","volume":"14","author":"Labandeira","year":"2020","journal-title":"Front. Neuroanat."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"20849","DOI":"10.1074\/jbc.R116.735894","article-title":"Why calcium? how calcium became the best communicator","volume":"291","author":"Carafoli","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41583-020-0278-2","article-title":"Presynaptic calcium channels: Specialized control of synaptic neurotransmitter release","volume":"21","author":"Dolphin","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature23484","article-title":"The primed SNARE-complexin-synaptotagmin complex for neuronal exocytosis","volume":"548","author":"Zhou","year":"2017","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1600-0854.2008.00759.x","article-title":"Vesicle docking in regulated exocytosis","volume":"9","author":"Verhage","year":"2008","journal-title":"Traffic"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-94-007-5561-1_5","article-title":"Intracellular calcium homeostasis and signaling","volume":"12","author":"Brini","year":"2013","journal-title":"Met. Ions Life Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3969023","DOI":"10.1155\/2016\/3969023","article-title":"Gq-Coupled Receptors in Autoimmunity","volume":"2016","author":"Zhang","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000186689","article-title":"Functions and regulatory mechanisms of Gq-signaling pathways","volume":"17","author":"Mizuno","year":"2009","journal-title":"Neurosignals"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2006.04.003","article-title":"PKD at the crossroads of DAG and PKC signaling","volume":"27","author":"Wang","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1152\/physrev.00033.2020","article-title":"Calcium-release channels: Structure and function of IP3 receptors and ryanodine receptors","volume":"102","author":"Woll","year":"2022","journal-title":"Physiol. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2017.09.055","article-title":"Mitostasis in neurons: Maintaining mitochondria in an extended cellular architecture","volume":"96","author":"Misgeld","year":"2017","journal-title":"Neuron"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1478-811X-9-19","article-title":"Calcium signaling around Mitochondria Associated Membranes (MAMs)","volume":"9","author":"Patergnani","year":"2011","journal-title":"Cell Commun. Signal"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1038\/onc.2008.308","article-title":"Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis","volume":"27","author":"Pinton","year":"2008","journal-title":"Oncogene"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0006-291X(03)00618-1","article-title":"Mitochondrial permeability transition: A common pathway to necrosis and apoptosis","volume":"304","author":"Kim","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbabio.2006.03.016","article-title":"Multiple pathways of cytochrome c release from mitochondria in apoptosis","volume":"1757","author":"Gogvadze","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pneurobio.2012.01.009","article-title":"GPCR mediated regulation of synaptic transmission","volume":"96","author":"Betke","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2016.11.001","article-title":"Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits","volume":"32","author":"Spangler","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fnmol.2019.00230","article-title":"Oligomeric Receptor Complexes and Their Allosteric Receptor-Receptor Interactions in the Plasma Membrane Represent a New Biological Principle for Integration of Signals in the CNS","volume":"12","author":"Fuxe","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/sj.bjp.0703892","article-title":"G(q\/11) and G(i\/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: Dependence on agonist as well as receptor-subtype","volume":"132","author":"Akam","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coph.2009.09.011","article-title":"Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms","volume":"10","author":"Hasbi","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1073\/pnas.1321576111","article-title":"Gq\/5-HT2c receptor signals activate a local GABAergic inhibitory feedback circuit to modulate serotonergic firing and anxiety in mice","volume":"111","author":"Spoida","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1073\/pnas.0905568107","article-title":"Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress","volume":"107","author":"McElligott","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.00036.2003","article-title":"Molecular structure and physiological functions of GABA(B) receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol. Rev."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Boczek, T., Mackiewicz, J., Sobolczyk, M., Wawrzyniak, J., Lisek, M., Ferenc, B., Guo, F., and Zylinska, L. (2021). The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines. Cells, 10.","DOI":"10.3390\/cells10051228"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1474-9726.2007.00283.x","article-title":"Calcium homeostasis and modulation of synaptic plasticity in the aged brain","volume":"6","author":"Foster","year":"2007","journal-title":"Aging Cell"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"103414","DOI":"10.1016\/j.mcn.2019.103414","article-title":"Role of GPCR signaling and calcium dysregulation in Alzheimer\u2019s disease","volume":"101","author":"Sushma","year":"2019","journal-title":"Mol. Cell Neurosci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbabio.2009.02.021","article-title":"Mitochondria, calcium and cell death: A deadly triad in neurodegeneration","volume":"1787","author":"Celsi","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Zampese, E., and Surmeier, D.J. (2020). Calcium, bioenergetics, and parkinson\u2019s disease. Cells, 9.","DOI":"10.3390\/cells9092045"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/026988110001400304","article-title":"HIV dementia: The role of the basal ganglia and dopaminergic systems","volume":"14","author":"Berger","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"133","DOI":"10.20517\/evcna.2022.14","article-title":"HIV-1 Tat induced microglial EVs leads to neuronal synaptodendritic injury: Microglia-neuron cross-talk in NeuroHIV","volume":"3","author":"Kannan","year":"2022","journal-title":"Extracell. Vesicles Circ. Nucl. Acids"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41423-019-0260-y","article-title":"NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology","volume":"17","author":"He","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1212\/WNL.43.10.2099","article-title":"Reduced basal ganglia volume in HIV-1-associated dementia: Results from quantitative neuroimaging","volume":"43","author":"Aylward","year":"1993","journal-title":"Neurology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00702-010-0415-6","article-title":"Increased dopaminergic neurotransmission in therapy-na\u00efve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses","volume":"117","author":"Scheller","year":"2010","journal-title":"J. Neural Transm."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-013-1086-x","article-title":"Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10\/10-repeat allele which is more frequent in HIV-infected individuals","volume":"120","author":"Horn","year":"2013","journal-title":"J. Neural Transm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002030-199401000-00010","article-title":"Cerebrospinal fluid dopamine in HIV-1 infection","volume":"8","author":"Berger","year":"1994","journal-title":"AIDS"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00001756-199603220-00015","article-title":"Dopamine deficits in the brain: The neurochemical basis of parkinsonian symptoms in AIDS","volume":"7","author":"Sardar","year":"1996","journal-title":"Neuroreport"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jnr.490280313","article-title":"Cerebrospinal fluid catecholamine metabolites in HIV-infected patients","volume":"28","author":"Larsson","year":"1991","journal-title":"J. Neurosci. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13550280902973952","article-title":"Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains","volume":"15","author":"Kumar","year":"2009","journal-title":"J. Neurovirol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13365-010-0003-4","article-title":"Human immunodeficiency virus infection in the CNS and decreased dopamine availability: Relationship with neuropsychological performance","volume":"17","author":"Kumar","year":"2011","journal-title":"J. Neurovirol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1124\/jpet.108.150144","article-title":"HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: Dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes","volume":"329","author":"Zhu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pharmthera.2017.10.007","article-title":"The role of human dopamine transporter in NeuroAIDS","volume":"183","author":"Zhu","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Strauss, M.J., Porter, K.D., Quizon, P.M., Davis, S.E., Lin, S., Yuan, Y., Martinez-Muniz, G.A., Sun, W.-L., Zhan, C.-G., and Zhu, J. (2022). Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0275182"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.120.266023","article-title":"[3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein","volume":"374","author":"Strauss","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acschemneuro.0c00792","article-title":"Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat","volume":"12","author":"Adeniran","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0002-9440(10)64304-0","article-title":"Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline","volume":"162","author":"Kim","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAD.0000000000002268","article-title":"Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy","volume":"33","author":"Henderson","year":"2019","journal-title":"AIDS"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fneur.2019.00285","article-title":"Release of soluble insulin receptor from neurons by cerebrospinal fluid from patients with neurocognitive dysfunction and HIV infection","volume":"10","author":"Gerena","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1073\/pnas.1308673110","article-title":"Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein","volume":"110","author":"Johnson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.122.001291","article-title":"Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice","volume":"384","author":"Davis","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/13550280903296346","article-title":"Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage","volume":"15","author":"Hu","year":"2009","journal-title":"J. Neurovirol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0006-8993(95)01166-8","article-title":"HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures","volume":"705","author":"Bennett","year":"1995","journal-title":"Brain Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/syn.20214","article-title":"Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function","volume":"59","author":"Wallace","year":"2006","journal-title":"Synapse"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/brain\/awh269","article-title":"Decreased brain dopaminergic transporters in HIV-associated dementia patients","volume":"127","author":"Wang","year":"2004","journal-title":"Brain"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/157016212802138724","article-title":"HIV-1 gp120 and drugs of abuse: Interactions in the central nervous system","volume":"10","author":"Silverstein","year":"2012","journal-title":"Curr. HIV Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jlb.65.4.458","article-title":"Molecular pathway involved in HIV-1-induced CNS pathology: Role of viral regulatory protein, Tat","volume":"65","author":"Rappaport","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1570162X13666150121110731","article-title":"HIV-1 proteins, Tat and gp120, target the developing dopamine system","volume":"13","author":"Fitting","year":"2015","journal-title":"Curr. HIV Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(00)02725-6","article-title":"Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum","volume":"879","author":"Bansal","year":"2000","journal-title":"Brain Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2009.09.113","article-title":"Dopaminergic neurotoxicity of HIV-1 gp120: Reactive oxygen species as signaling intermediates","volume":"1306","author":"Agrawal","year":"2010","journal-title":"Brain Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00126334-200210012-00005","article-title":"Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120","volume":"31","author":"Haughey","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.1471-4159.1999.0731363.x","article-title":"Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat","volume":"73","author":"Haughey","year":"1999","journal-title":"J. Neurochem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/exnr.1998.6958","article-title":"HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress","volume":"154","author":"Kruman","year":"1998","journal-title":"Exp. Neurol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s13365-020-00861-0","article-title":"Intersecting roles of ER stress, mitochondrial dysfunction, autophagy, and calcium homeostasis in HIV-associated neurocognitive disorder","volume":"26","author":"Andhavarapu","year":"2020","journal-title":"J. NeuroVirology"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3940(95)11940-X","article-title":"Neurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virus","volume":"197","author":"Strijbos","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2001.00396.x","article-title":"HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity","volume":"78","author":"Haughey","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Norman, J.P., Perry, S.W., Reynolds, H.M., Kiebala, M., De Mesy Bentley, K.L., Trejo, M., Volsky, D.J., Maggirwar, S.B., Dewhurst, S., and Masliah, E. (2008). HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003731"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1389450116666150531162212","article-title":"HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions","volume":"17","author":"Hu","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/cercor\/bhp274","article-title":"The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings","volume":"20","author":"Musante","year":"2010","journal-title":"Cereb. Cortex"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1523\/JNEUROSCI.23-17-06810.2003","article-title":"The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms","volume":"23","author":"Feligioni","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/acschemneuro.5b00001","article-title":"Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter","volume":"6","author":"Yuan","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0074-7742(07)82018-6","article-title":"Effects of the HIV-1 viral protein TAT on central neurotransmission: Role of group I metabotropic glutamate receptors","volume":"Volume 82","author":"Neri","year":"2007","journal-title":"Neuroinflammation in Neuronal Death and Repair"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbi.2017.05.004","article-title":"HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function","volume":"65","author":"Kesby","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugalcdep.2017.04.015","article-title":"HIV Tat excites D1 receptor-like expressing neurons from rat nucleus accumbens","volume":"178","author":"Brailoiu","year":"2017","journal-title":"Drug Alcohol. Depend."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbi.2019.08.191","article-title":"Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway","volume":"82","author":"Mackie","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11481-018-9825-2","article-title":"Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders","volume":"14","author":"Nolan","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","article-title":"HIV-associated neurocognitive disorder-pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1007\/s00018-021-03785-y","article-title":"Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders","volume":"78","author":"Irollo","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"12850","DOI":"10.1523\/JNEUROSCI.5351-13.2014","article-title":"Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na\u207a influx, mitochondrial instability, and Ca\u00b2\u207a overload","volume":"34","author":"Fitting","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Smith, L.K., Babcock, I.W., Minamide, L.S., Shaw, A.E., Bamburg, J.R., and Kuhn, T.B. (2021). Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248309"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1007\/s00253-020-10614-y","article-title":"Crosstalk between ER stress, NLRP3 inflammasome, and inflammation","volume":"104","author":"Li","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3462530","DOI":"10.1155\/2019\/3462530","article-title":"ER stress activates the NLRP3 inflammasome: A novel mechanism of atherosclerosis","volume":"2019","author":"Chen","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41420-023-01360-x","article-title":"XBP1 modulates endoplasmic reticulum and mitochondria crosstalk via regulating NLRP3 in renal ischemia\/reperfusion injury","volume":"9","author":"Ni","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_168","first-page":"216","article-title":"Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells","volume":"8","author":"Guerri","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/20\/15340\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:09:27Z","timestamp":1760130567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/20\/15340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":170,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ijms242015340"],"URL":"https:\/\/doi.org\/10.3390\/ijms242015340","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]}}}